David H. Raulet

39.8k total citations · 17 hit papers
220 papers, 32.3k citations indexed

About

David H. Raulet is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David H. Raulet has authored 220 papers receiving a total of 32.3k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Immunology, 40 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in David H. Raulet's work include Immune Cell Function and Interaction (192 papers), T-cell and B-cell Immunology (165 papers) and Immunotherapy and Immune Responses (46 papers). David H. Raulet is often cited by papers focused on Immune Cell Function and Interaction (192 papers), T-cell and B-cell Immunology (165 papers) and Immunotherapy and Immune Responses (46 papers). David H. Raulet collaborates with scholars based in United States, France and Japan. David H. Raulet's co-authors include Andreas Diefenbach, Russell E. Vance, A. M. Jamieson, Stephan Gasser, Mark Bix, Werner Held, Christopher W. McMahon, Éric Vivier, Richard D. Garman and James G. McArthur and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David H. Raulet

219 papers receiving 31.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Innate or Adaptive Immunity? The Example of Natural Killer Cells

2011 2.0k citations David H. Raulet, Michael A. Caligiuri et al. profile →
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1992 1.4k citations David H. Raulet et al. profile →
Roles of the NKG2D immunoreceptor and its ligands

2003 1.1k citations David H. Raulet profile →
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

2005 1.0k citations Stephan Gasser, David H. Raulet et al. profile →
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells

1990 878 citations David H. Raulet et al. profile →
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

2001 850 citations A. M. Jamieson, David H. Raulet et al. profile →
Developmental potential and dynamic behavior of hematopoietic stem cells

1986 725 citations David H. Raulet et al. profile →
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

2000 692 citations A. M. Jamieson, David H. Raulet et al. profile →
Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease

2004 647 citations David H. Raulet, Veronika Groh et al. profile →
NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

2008 647 citations Nadia Guerra, Nathalie T. Joncker et al. profile →
Regulation of Ligands for the NKG2D Activating Receptor

2013 643 citations David H. Raulet, Stephan Gasser et al. profile →
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

2018 609 citations Alexandre Iannello, David H. Raulet et al. profile →
The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing

2002 537 citations A. M. Jamieson, Christopher W. McMahon et al. profile →
Properties and Applications of Monoclonal Antibodies Directed against Determinants of the Thy-1 Locus

1979 536 citations David H. Raulet et al. The Journal of Immunology profile →
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response

2018 462 citations Russell E. Vance, David H. Raulet et al. profile →
Developmental regulation of T-cell receptor gene expression

1985 456 citations David H. Raulet et al. profile →
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

2022 318 citations Natalie K. Wolf, Djem Kissiov et al. profile →

Peers

Countries citing papers authored by David H. Raulet

Since Specialization

Citations

This map shows the geographic impact of David H. Raulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Raulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Raulet more than expected).

Fields of papers citing papers by David H. Raulet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Raulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Raulet. The network helps show where David H. Raulet may publish in the future.

Co-authorship network of co-authors of David H. Raulet

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Raulet. A scholar is included among the top collaborators of David H. Raulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Raulet. David H. Raulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Binary outcomes of enhancer activity underlie stable random monoallelic expression 2022 ·eLife ·Djem Kissiov, (unknown), Sean Chen, Natalie K. Wolf, Chen‐Yu Zhang, (unknown), Yeara Jo, (unknown), Ishan Paranjpe, Angus Y. Lee, (unknown), Stefan A. Muljo, David H. Raulet	9
2	Millikelvin-resolved ambient thermography 2020 ·Science Advances ·Kechao Tang, Kaichen Dong, Christopher J. Nicolai, Ying Li, Jiachen Li, Shuai Lou, Cheng‐Wei Qiu, David H. Raulet, Jie Yao, Junqiao Wu	34
3	Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging 2019 ·JCI Insight ·Denise P. Muñoz, Steven M. Yannone, Anneleen Daemen, Yu Sun, Funda Vakar‐Lopez, Misako Kawahara, Adam Freund, Françis Rodier, Jennifer D. Wu, Pierre-Yves Desprez, David H. Raulet, Peter S. Nelson, Laura van ‘t Veer, Judith Campisi, Jean-Philippe Coppé	118
4	MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions 2017 ·Cancer Immunology Research ·Amanda R. Campbell, Megan Duggan, Lorena P. Suarez‐Kelly, (unknown), (unknown), Elizabeth L. McMichael, Prashant Trikha, Robin Parihar, (unknown), (unknown), Bryant C. Yung, Robert J. Lee, David H. Raulet, Susheela Tridandapani, Veronika Groh, Lianbo Yu, Vedat Yildiz, John C. Byrd, Michael A. Caligiuri, William E. Carson	15
5	Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells 2016 ·Cancer Discovery ·Asaf Spiegel, Mary W. Brooks, (unknown), Ferenc Reinhardt, Michele Ardolino, Evelyn Fessler, Michelle B. Chen, Jordan A. Krall, Jasmine DeCock, Ioannis K. Zervantonakis, Alexandre Iannello, Yoshiko Iwamoto, Virna Cortez‐Retamozo, Roger D. Kamm, Mikäel J. Pittet, David H. Raulet, Robert A. Weinberg	370
6	Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness 2016 ·The Journal of Immunology ·Nataliya Tovbis Shifrin, Djem Kissiov, Michele Ardolino, Nathalie T. Joncker, David H. Raulet	5
7	RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma 2014 ·Cancer Research ·(unknown), Nina Le Bert, Samantha S.W. Ho, Yu J. Shen, (unknown), Gordon M. Xiong, J. Ludovic Croxford, Christine X. Koo, Ken J. Ishii, Shizuo Akira, David H. Raulet, Stephan Gasser	128
8	Impaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice 2012 ·Blood ·Simon Bélanger, Megan M. Tu, Mir Munir A. Rahim, Ahmad Bakur Mahmoud, Rajen Patel, Lee‐Hwa Tai, (unknown), Brian T. Wilhelm, Josette‐Renée Landry, Qinzhang Zhu, Kenneth S. K. Tung, David H. Raulet, Andrew P. Makrigiannis	56
9	Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis 2011 ·Circulation ·Mingcan Xia, Nadia Guerra, Galina K. Sukhova, Kangkang Yang, Carla K. Miller, Guo‐Ping Shi, David H. Raulet, Na Xiong	52
10	Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment 2010 ·The Journal of Experimental Medicine ·Nathalie T. Joncker, Nataliya Tovbis Shifrin, Frédéric Delebecque, David H. Raulet	180
11	Chemotherapy-Induced Genotoxic Stress Promotes Sensitivity to Natural Killer Cell Cytotoxicity by Enabling Missing-Self Recognition 2010 ·Cancer Research ·Jason H. Fine, Peter Chen, Aruz Mesci, David Allan, Stephan Gasser, David H. Raulet, James R. Carlyle	85
12	The Role of NKG2D Signaling in Inhibition of Cytotoxic T-Lymphocyte Lysis by the Murine Cytomegalovirus Immunoevasin m152 /gp40 2007 ·Journal of Virology ·Amelia K. Pinto, A. M. Jamieson, David H. Raulet, Ann B. Hill	9
13	A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules 2005 ·Blood ·Nadine Fernandez, Emmanuel Treiner, Russell E. Vance, A. M. Jamieson, Suzanne Lemieux, David H. Raulet	419
14	Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response 2004 ·The Journal of Immunology ·Marielle C. Gold, Michael W. Munks, Markus Wagner, Christopher W. McMahon, Ann Marie Kelly, Daniel G. Kavanagh, Mark K. Slifka, Ulrich H. Koszinowski, David H. Raulet, Ann B. Hill	61
15	Genomic Ly49A Transgenes: Basis of Variegated Ly49A Gene Expression and Identification of a Critical Regulatory Element 2004 ·The Journal of Immunology ·(unknown), (unknown), Dragana Cado, (unknown), Jennifer K. Hsia, David H. Raulet	30
16	Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions 2004 ·The Journal of Immunology ·A. M. Jamieson, (unknown), Jeffrey R. Dorfman, Mark Coles, David H. Raulet	132
17	Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro 2002 ·The Journal of Immunology ·(unknown), Motoi Maeda, Stefan Lohwasser, Marc Delcommenne, Toru Nakano, Russell E. Vance, David H. Raulet, Fumio Takei	35
18	Cumulative Inhibition of NK Cells and T Cells Resulting from Engagement of Multiple Inhibitory Ly49 Receptors 2001 ·The Journal of Immunology ·Thomas Hanke, David H. Raulet	24
19	Viral Infections Induce Abundant Numbers of Senescent CD8 T Cells 2001 ·The Journal of Immunology ·David Voehringer, Claudine Blaser, Pierre Brawand, David H. Raulet, Thomas Hanke, Hanspeter Pircher	199
20	NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules 2000 ·European Journal of Immunology ·Laura G. Corral, Thomas Hanke, Russell E. Vance, Dragana Cado, David H. Raulet	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact